1. JAK/STAT Signaling Stem Cell/Wnt Apoptosis Immunology/Inflammation NF-κB Metabolic Enzyme/Protease Cell Cycle/DNA Damage Epigenetics
  2. STAT Apoptosis Reactive Oxygen Species (ROS) PARP
  3. KB-15

KB-15 is a STAT3 inhibitor. KB-15 exhibits potent anti-proliferative activity against AGS gastric cancer cells (IC50 = 0.29 μM) and BGC-823 gastric cancer cells (IC50 = 0.65 μM). KB-15 exerts anti-tumor effects by inhibiting STAT3 phosphorylation, downregulating HO-1 expression, and promoting intracellular ROS accumulation. KB-15 induces G0/G1 phase cell cycle arrest and apoptosis, as well as suppresses colony formation and migration of gastric cancer cells. KB-15 demonstrates excellent anti-tumor efficacy in BGC-823 subcutaneous xenograft model. KB-15 can be used for the study of gastric cancer.

For research use only. We do not sell to patients.

KB-15

KB-15 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

KB-15 is a STAT3 inhibitor. KB-15 exhibits potent anti-proliferative activity against AGS gastric cancer cells (IC50 = 0.29 μM) and BGC-823 gastric cancer cells (IC50 = 0.65 μM). KB-15 exerts anti-tumor effects by inhibiting STAT3 phosphorylation, downregulating HO-1 expression, and promoting intracellular ROS accumulation. KB-15 induces G0/G1 phase cell cycle arrest and apoptosis, as well as suppresses colony formation and migration of gastric cancer cells. KB-15 demonstrates excellent anti-tumor efficacy in BGC-823 subcutaneous xenograft model. KB-15 can be used for the study of gastric cancer[1].

In Vitro

KB-15 (72 h) exhibits potent anti-proliferative activity against AGS gastric cancer cells (IC50 = 0.29 μM) and BGC-823 gastric cancer cells (IC50 = 0.65 μM)[1].
KB-15 (0.25-2 μM, 14 days) shows potent colony formation inhibitory activity against AGS and BGC-823 gastric cancer cells[1].
KB-15 (0.5-2 μM, 24 h) demonstrates potent ROS-inducing activity in BGC-823 cells[1].
KB-15 (0.25-2 μM, 24-36 h) exhibits potent G0/G1 phase arrest activity and induces apoptosis in AGS and BGC-823 cells[1].
KB-15 (0.5-2 μM, 24 h) inhibits STAT3 activation in a concentration-dependent manner and downregulates HO-1 in BGC-823 cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cycle Analysis[1]

Cell Line: AGS and BGC-823 cells
Concentration: 0.25, 0.5, 1, 2 μM
Incubation Time: 36 h
Result: Induced concentration-dependent increase in the proportion of G0/G1 phase cells.

Apoptosis Analysis[1]

Cell Line: BGC-823 cells
Concentration: 0.5, 1, 2 μM
Incubation Time: 24 h
Result: Increased the total apoptosis rate in a concentration-dependent manner.
Upregulated pro-apoptotic proteins Cleaved-PARP and Bax.

Western Blot Analysis[1]

Cell Line: BGC-823 cells
Concentration: 0.5, 1, 2 μM
Incubation Time: 24 h
Result: Inhibited STAT3 activation in a concentration-dependent manner and downregulated HO-1.
In Vivo

KB-15 (2.5 mg/kg, i.p., once daily, 14 consecutive days) demonstrates excellent anti-tumor efficacy in BGC-823 subcutaneous xenograft model[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: BGC-823 cells (5 × 107 in serum-free medium) were subcutaneously implanted into the left axillary area of 6-week-old male BALB/c (nu/nu) nude mice[1]
Dosage: 2.5 mg/kg
Administration: i.p. once daily for 14 consecutive days
Result: Achieved a tumor growth inhibition (TGI) rate of 53.3% at a dose of 2.5 mg/kg.
Reduced the expression of phosphorylated STAT3 (p-STAT3) and HO-1 protein in BGC-823 xenograft tumor tissues.
Increased the expression of pro-apoptotic proteins Cleaved-PARP and Bax, and decreased the expression of apoptotic protease Procaspase-3 in tumor tissues.
Molecular Weight

430.11

Formula

C18H12Cl4N2O2

SMILES

ClC1=C(Cl)C=CC(/C=C/C(NNC(/C=C/C2=CC(Cl)=C(Cl)C=C2)=O)=O)=C1

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
KB-15
Cat. No.:
HY-175542
Quantity:
MCE Japan Authorized Agent: